Home > Journals > Italian Journal of Vascular and Endovascular Surgery > Past Issues > Italian Journal of Vascular and Endovascular Surgery 2015 December;22(4) > Italian Journal of Vascular and Endovascular Surgery 2015 December;22(4):189-95

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLES   

Italian Journal of Vascular and Endovascular Surgery 2015 December;22(4):189-95

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Long-term performance of Gore® EXCLUDER® AAA Endoprosthesis: a single center’s experience

Lösel-Sadée H.

Department of Vascular Surgery, Sana Kliniken Düsseldorf, Düsseldorf, Germany


PDF


AIM: The aim of this study was to assess the effectiveness of endovascular aneurysm repair (EVAR), specifically assessing the durability of EVAR utilizing the Gore® EXCLUDER® AAA Endoprosthesis by analyzing the long-term performance as it relates to reinterventions, patency and presence of aneurysm rupture.
METHODS: Patients undergoing elective endovascular AAA (abdominal aortic aneurysm) repair with the Gore® EXCLUDER® Endoprosthesis at the Sana Clinic in Düsseldorf, Germany were analyzed. Follow-up included routine contrast-enhanced computed tomography at 1, 6, and 12 months and annually thereafter. Average operating time was 116.2 minutes, with no difference noted between use of the EXCLUDER® featuring the Gore® SIM-PULL or C3 Delivery Systems (116.1 vs. 116.3 min respectively).
RESULTS: A total of 144 patients (122 men and 2 women) underwent EVAR with the Gore® Excluder® AAA Endoprosthesis between December 2004 and December 2012. The mean follow-up time was 13.8 months, and the longest recorded follow-up was 67.6 months. There was no migration nor type I or type III endoleaks during the follow-up period. Seven (5.8%) of the 121 patients required reintervention to treat a type II endoleak. Limb thrombosis was present in 1 (0.8%) patient. No patient was identified with aneurysmal rupture postimplant. Also, no patient presented with aneurysm diameter growth of more than 5 mm at any point during follow-up.
CONCLUSION: EVAR provides a safe and durable minimally invasive treatment method for the majority of patients presenting with AAA. Late failures of Gore® EXCLUDER® AAA Endoprosthesis are rare. Excellent patency, low reinterventions and consistent rupture prevention demonstrate long-term device durability.

top of page